Table 1.

EC50_s for positive compounds

primary screening	EC50 (µM)	similarity analysis	EC50 (µM)
Prevention		Prevention
norfloxacin	3.67	rolitetracycline	4.03
5’-AMP*	6.05	oxytetracycline	2.49
doxycycline	0.5	methacycline	1.44
tetracycline	0.33	gatifloxacin	2.19
chlorotetracycline	1.15	levofloxacin	2.19
minocycline	0.24	enoxacin	13.87
meclocycline	0.55	flumequine	58.2
ciprofloxacin	1.09	lomefloxacin	27.77
moxifloxacin	0.8	ofloxacin	12.55
CPA†	2.67	sarafloxacin	0.7
Mitigation
linoleic acid	8.51
scopolamine	9.86
rifabutin	4.11
vidarabine	7.83
acivicin	1.13
deoxyadenosine	8.23
tilorone	2.49

^*adenosine 5’-monophosphate

^†cyclopiazonic acid